Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ferumoxytol Nanozymes for Biofilm Disruption: A Clinical Study

NCT07518901 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT07518901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07518901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ferumoxytol Nanozymes for Biofilm Disruption: A Clinical Study
Lead sponsor
University of Pennsylvania
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
August 24, 2026
Completion date
June 30, 2028
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

apical periodontitis, endodontic disease, root canal infection